By proceeding, you agree to our Terms of Use and Privacy Policy.
BSP Pharmaceuticals S.p. A. is focused on the development and manufacturing of anticancer drugs with high potency and cytotoxitc characteristics for the Pharmaceuticals Industry. BSP has been at the forefront in the fight agains cancer since 2006.
06-09 September 2022
3 years since we last brought the community together in-person in San Diego we are excited to once more unite 600+ ADC enthusiasts at the World’s Definitive Antibody-Drug Conjugate Event.
Event Ended
USA
Paid
San Diego
20-22 September 2022
The Newly Re-Branded 13th World Multispecifics Summit is the Only End-to-End Meeting Committed Solely to Advancing the Development of Bi- & Multi-Specific Therapeutics With more clinical candidates and commercial success than ever within this rapidly
Boston
21-23 February 2023
With numerous next-generation conjugate companies recently receiving their INDs to enter the clinic including Avidity Biosciences and Dyne Therapeutics and many more following closely in their footsteps, conjugate drugs comprising of novel payloads a
22-24 February 2023
The increasing incidence of cancer and the ever-rising demand for anticancer drugs results in significant growth for the highly potent active pharmaceutical ingredients (HPAPIs) market.
Virtual
Free
13-16 March 2023
The 13th Annual World ADC London returns in 2023 as Europe’s longest standing and definitive antibody-drug conjugate event - and it’s back bigger and better than before! With the recent approval of Astrazeneca and Daiichi Sankyo’s DESTINY-Breast04, s
UK
London
25-27 April 2023
As ADCs as a modality see continued clinical progress, drug developers are becoming more creative with their drug design and new analytical technologies are improving the resolution so that you can understand the characteristics of your drug.
02-04 October 2023
Join us for the 14th World Bispecific Summit in 2023, where we celebrate the remarkable advancements and immense potential of bispecific antibody treatments. In this pivotal year, bispecific antibody therapies have emerged as formidable contenders in
16-19 October 2023
Join us at the 14th World ADC San Diego conference, where the revolutionary field of antibody-drug conjugates (ADCs) continues to make remarkable strides in the oncology landscape. In the year 2023, the ADC renaissance reaches new heights with the ea
18-19 April 2024
Join us at the MarketsandMarkets High Potent Medicines Conference, taking place on 19th - 20th October 2023, in Boston, USA. This groundbreaking conference is designed to address the emerging trends and challenges in the high potent medicines market.